Vor Biopharma (VOR)

• Market cap: $720M
• 1 day: -0.08%
• 5 days: -2.78%
• 1 month: -23.01%
• 3 months: -14.1%
• 6 months: 23.88%
• Year to date: 14.09%
• 1 year: 197.76%
• 5 years: -96.82%
• 10 years: -98.23%
• Sector: Healthcare
• Industry: Biotechnology

About: Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.

Employees: 76